Kit Delgado Elected to American Society for Clinical Investigation
One of Only a Few Emergency Physicians Ever Inducted into ASCI
Health Care Access & Coverage
Blog Post
Opioid prescribing has fallen dramatically in recent years. The same cannot be said for chronic pain, which afflicts over 20 percent of adults in the U.S. Ensuring that people with pain have access to safe, effective, and affordable nonopioid pain management is critical.
The AHRQ recommends acupuncture for various pain conditions, including low back pain, neck pain, and fibromyalgia. Despite these recommendations, insurance coverage for acupuncture has been inconsistent historically. In a new study, we found that insurance coverage for acupuncturist visits is increasing nationally, which aligns with Medicare’s decision to cover acupuncture for low back pain. As expected, the utilization of acupuncture increased along with expanded coverage. However, we also found that half of spending on acupuncturist visits was paid out-of-pocket in 2019, making it cost-prohibitive relative to other forms of pain management.
To support people with pain amidst the drop-off in opioid prescribing, insurers should be encouraged to cover nonopioid, evidence-based pain management. More research is needed to understand why and how insurers reimburse acupuncture, how to incorporate it into a comprehensive pain management regimen, and whether it can benefit people with pain who previously relied on opioids.
The study, Trends in Insurance Coverage for Acupuncture, 2010-2019, was published in JAMA Network Open on January 12, 2022. Authors include Molly Candon, Arya Nielsen, and Jeffery A. Dusek.
One of Only a Few Emergency Physicians Ever Inducted into ASCI
Challenges and Opportunities to Using Insurance Data to Analyze Abortion Care
Penn LDI Study Examines Insurance Claims to Learn More about Patients Who Get Acupuncture
But Many Services Were Only Extended Until March 2025
Recipient of 2024 Samuel Martin Health Evaluation Sciences Research Award
A Digest of LDI Research on Equity, Costs, and Care in Medicare Advantage Over The Last Two Years
Report from His Penn Fireside Chat with Ezekiel Emanuel about Drug Pricing